Women’s health issues: the trouble with “just lose weight”

Photography: ©Rawpixel.com / Adobe Stock

Women’s health issues include chronic pain, heart disease, bone health and the consequences of being dismissed. So why does the conversation keep coming back to babies and smaller waistlines?

Editorial update: Originally published July 8, 2019, by Madison Salters, a 2018 URevolution Fellow. Revised September 30, 2026, with updated research and U.S. guidance by URevolution’s editorial team. Madison’s authorship and original argument are retained.

Content note: Discussion of weight stigma, restrictive dieting and eating disorders.

Women’s health. You’d think that, having been allotted our own category, we might at least get the whole body included.

A heart, for instance. Bones. The persistent pain that has become a part-time job to explain. Yet “women’s health” still gets squeezed into two familiar conversations: what our bodies can reproduce, and how much space they are allowed to occupy.

There is always room for another product promising to make that space smaller.

On September 15, 2026, the FDA warned consumers not to buy or use Beauty 911, a product sold for weight loss. Testing found undeclared sibutramine, a drug withdrawn from the market over safety concerns. It can raise blood pressure or heart rate and interact dangerously with other medicines.

Beauty 911. An unfortunate name for something that might create its own emergency.

That warning is one reason to return to this article now. Another is the growing research on what happens to bones during treatment with newer weight-management medicines. These are different stories, and they deserve different conclusions. An illegal product with a hidden drug is not interchangeable with an approved prescription. Neither story, however, can be understood by asking only whether somebody got thinner.

What are women’s health issues?

Women’s health issues are conditions and healthcare experiences that affect women’s physical and mental health throughout life. They include reproductive and sexual health, but also cardiovascular disease, chronic pain, autoimmune conditions, mental illness, osteoporosis and the barriers that prevent people from receiving appropriate care.

Some conditions involve anatomy or hormones. Others affect people of every gender but may be studied, recognized or treated differently in women. Gender bias in healthcare is part of the subject, too: what happens when a clinician’s assumptions get to the examination room before the patient does?

A woman with chronic illness does not leave that illness outside the door when she attends a gynecology appointment. Nor should her pain, fatigue or medication side effects disappear behind a discussion of her weight. For disabled women, appropriate care also means accessible examination equipment, communication that works and appointments they can actually attend.

This article concentrates on the overlap between medical bias, pressure to be thin and bone health. It is not a screening schedule for every condition a woman might develop.

And there is no single female body. Where a study describes female participants, that is the population its findings concern; it does not automatically tell us how the results apply to every trans, intersex or nonbinary person. Care should account for a person’s anatomy, hormone exposure, medical history and circumstances. Madison’s companion article on LGBT discrimination in healthcare examines those barriers in more detail.

Who gets studied, and who gets believed?

The history is bad enough without exaggerating it.

As the NIH’s account of women’s participation in research explains, women were excluded from important areas of medical research, including through restrictions intended to protect potential pregnancies. Protection can become a peculiar word when it leaves the person who is already here without reliable information about her own treatment.

But it would be inaccurate to say women are still absent from drug trials, or that almost every modern dose is simply a man’s dose handed to a woman. The NIH Revitalization Act of 1993 made inclusion of women and minorities in NIH-supported clinical research a legal requirement. That does not mean every question has been answered, every population is adequately represented, or every study is large enough to investigate meaningful differences.

Counting women in a study and producing evidence that helps women are related tasks. They are not the same task.

Journalist Maya Dusenbery’s Doing Harm connects two failures: gaps in medical knowledge about women, and the tendency to distrust women’s accounts of their symptoms. Her reporting supplies a useful way to think about the problem. Less knowledge can make a symptom harder to explain; disbelief can make the search for an explanation stop too soon.

Does research show a gender pain gap?

A 2024 study in PNAS examined emergency-department records and conducted a controlled experiment. Its findings showed a disadvantage for female patients in pain-management decisions, including a lower likelihood of receiving pain-relief prescriptions. The research supports concern about bias in the settings studied. It does not prove that every delayed diagnosis is discrimination, or that every woman receives worse care than every man.

It does give us something more useful than telling women they imagined the pattern.

Being taken seriously should not require performing illness convincingly enough. A patient may be articulate, neatly dressed, anxious, angry or very tired. None of those things is a pain test. A mental health condition also deserves treatment in its own right; it should not become a convenient reason to stop investigating physical symptoms.

Get thin! Or diet trying

The sales pitch has extraordinary stamina. The product changes; the problem is still supposed to be your body.

A smaller waist becomes evidence of discipline. Weight loss becomes a compliment before anyone asks whether the person has been ill, unable to afford food, grieving or struggling with an eating disorder. Meanwhile, a larger body can be treated as an explanation for symptoms that have barely been discussed.

In What We Don’t Talk About When We Talk About Fat, writer and commentator Aubrey Gordon shifts attention from individual self-esteem to the systems that exclude fat people, including healthcare. It is a useful correction to the idea that the whole problem could be solved if everyone just learned to love their reflection.

A person can feel perfectly comfortable in her body and still need a blood-pressure cuff that fits. She can dislike her body and still deserve a careful diagnosis. Confidence is not an admission fee.

URevolution’s doctor’s open apology for fat shaming offers a clinician’s perspective on what happens when judgment substitutes for care.

Eating disorders do not have a required body size

The National Institute of Mental Health describes eating disorders as serious illnesses that can affect people at any body weight. Someone who appears healthy can be extremely unwell. Restriction, binge eating, purging or distress around food deserve attention without a patient first having to become visibly thin.

Diet culture is part of the social context; it is not a complete explanation for a complex illness. Eating disorders involve biological, psychological and social factors. They are not vanity, and they are not a failure of willpower.

Miriam Swallow Adler’s personal account of medical gaslighting describes the harm of having concerns about eating overshadowed by pressure to lose weight. It is a lived experience, not a diagnostic checklist, and that distinction matters.

A supplement label is not a safety certificate

The FDA’s September warning is a specific finding about a specific product. It is not evidence that every supplement contains an undeclared drug. But the agency also warns that products contaminated with hidden ingredients are dangerous and illegal, and that it cannot identify every contaminated product on sale.

“Natural” does a remarkable amount of unpaid public-relations work.

The relevant questions are less decorative: what is in this product, what evidence supports its claims, and could it interact with medication? Those questions are especially consequential for someone already managing a chronic condition and several prescriptions.

A bone to pick with dieting

Bones are living tissue. They do not receive a congratulatory email when a dress size changes.

Osteoporosis weakens bone and increases the likelihood of fractures. It can remain unnoticed until a bone breaks. According to NIAMS, the NIH institute responsible for musculoskeletal health research, risk reflects several factors, including aging, family history, hormonal changes, some medical conditions and certain medicines. Falling estrogen around menopause is part of that picture.

Excessive dietary restriction, inadequate protein and poor calcium or vitamin D intake can also matter. That supports concern about undernourishment. It does not support blaming every fracture on dieting, declaring all thin women unhealthy, or claiming that one country’s changing beauty standards explain its future osteoporosis rates.

For women living with chronic illness, the conversation may also involve long-term glucocorticoid treatment, conditions that affect nutrition, or periods when movement is limited. None of that is a moral failure. Nobody should be told to discontinue an essential medicine because an article mentions bone health; the useful next step is a conversation about managing the risk.

Food and movement advice needs to survive contact with real life. A person with pain, exhaustion or limited mobility may need practical support and adapted activity. Handing her an ambitious gym routine and calling the job done is an impressively efficient way to provide no help at all.

What does newer weight-loss research say about bones?

Prescription weight-management treatment deserves evidence rather than a culture-war loyalty test. Some medicines offer benefits beyond weight loss. In 2024, for example, the FDA approved Wegovy to reduce major cardiovascular events in adults with established cardiovascular disease and either overweight or obesity. That is a defined clinical use, not a promise that everybody should take it.

The bone-health questions remain worth asking.

A 2026 study published in The Journal of Clinical Endocrinology & Metabolism compared 255 semaglutide or tirzepatide users with 255 matched nonusers. In the medication group, 92% were female and the average age was 64. Both groups lost bone mineral density at the hip and femoral neck; overall losses were similar between groups. In the subgroup without diabetes, medication users had greater annualized total-hip bone loss than controls.

That is more complicated than “weight-loss drugs destroy women’s bones.” It was a retrospective, single-center study, not a randomized trial proving that the medicines caused fractures. Bone-density changes are also not the same outcome as broken bones. The findings justify attention to an individual’s bone health; they do not settle the risks for every drug, dose, age group or patient.

For someone considering treatment, the sensible discussion includes its intended benefits, nutritional intake, side effects, strength and fracture risk. For someone already taking it, a frightening headline is a reason to ask questions, not to change a prescription alone.

Weight stigma should not drive someone into treatment or shame them out of it. Lili Lujza’s essay about her mother’s gastric bypass surgery explores the family experience of weight, illness and judgment. It should be read as that family’s story, not as evidence that surgery has the same outcome for everyone.

What should better care for women include?

Start with a healthcare conversation in which the body is allowed to be more interesting than its measurements.

When should women ask about osteoporosis screening?

The U.S. Preventive Services Task Force’s January 2025 recommendation supports screening women aged 65 and older. It also supports screening postmenopausal women younger than 65 when clinical risk assessment identifies increased fracture risk. A DXA scan measures bone mineral density.

This routine-screening recommendation is not a reason to wait if you have already had a fragility fracture, have known osteoporosis, or have a condition or medicine associated with secondary bone loss. Those situations need their own assessment and management plan. A birthday alone does not answer the question.

What helps protect bone health?

Adequate calcium and vitamin D support bones, but supplements are not a universal fix. Food sources can include dairy or suitable fortified alternatives; individual needs and any supplementation should be discussed when intake is inadequate or medical circumstances complicate the picture.

Weight-bearing and resistance exercise can support bone health, with balance work helping reduce falls. The activity needs to be appropriate to the person. Existing fractures, osteoporosis or other limitations may require guidance from a clinician or physical therapist. Prevention and treatment can also include medication; healthy habits do not replace indicated care.

What can you ask when your symptoms are dismissed?

A few questions can make the next step clearer:

• “What else could explain these symptoms?”
• “What have we ruled out, and what remains uncertain?”
• “Could my medicines, eating difficulties or hormonal changes be relevant?”
• “What should happen if this plan does not help, and when should I seek care sooner?”

Bring a symptom timeline or a trusted person if that helps. Ask for an explanation you can understand and a follow-up plan you can use. Our guide to getting a doctor to take your symptoms seriously offers more preparation ideas.

None of this makes a patient responsible for fixing medical bias. People who cannot prepare a perfect account, afford another appointment or calmly advocate for themselves still deserve competent care.

Women have spent quite enough time getting the shorter end of the stethoscope. A healthcare system should be able to consider our pain, our bones and the lives we are trying to live without first asking whether we could become a slightly smaller version of ourselves.

That would be a useful definition of women’s health.

This is evidence-informed editorial commentary, not individualized medical advice or a documented clinical review. For personal decisions about screening, nutrition or medication, speak with a qualified healthcare professional.